Jennifer (Ying) Lan

With a focus on investment-grade debt, advises U.S. and global issuers and underwriters on public and private capital markets transactions.
Jenn focuses on investment-grade debt offerings and advises both U.S. and global issuers and underwriters, including all of the major U.S. investment banks, on various public and private capital markets transactions. She also has extensive experience handling IPOs, other equity offerings, high-yield debt offerings, liability management and acquisition financings.
Her practice ranges across a variety of industries, including biotech/pharma, financial and consulting services, insurance, technology, consumer retail and industrials.
A variety of large and mid-cap companies and emerging growth companies also seek Jenn’s advice on general corporate matters, including corporate governance and securities law matters.
Experience
Recent Work
- Air Products and Chemicals €1 billion notes offering
- IBM $4.75 billion and €3.5 billion notes offering
- Fifth Third Bank $1 billion senior notes offering
- IDEX $500 million notes offering
- Aptiv €750 million senior notes offering
- Schlumberger Investment $500 million senior notes offering
- Schlumberger Holdings $1 billion senior notes offering
- Illinois Tool Works €1.5 billion notes offering
- Atlassian $1 billion debut senior notes offering
- General Mills €1 billion notes offering
- Fiserv $2 billion notes offering
- Bristol Myers Squibb $13 billion notes offering
- Cardinal Health $1.15 billion notes offering
- Eastman Chemical $750 million notes offering
- Marsh McLennan $1 billion senior notes offering
- Eli Lilly $6.5 billion notes offering
Recognition
IFLR Americas Awards – “Rising Stars – International Firms,” 2022
Education
Qualifications and admissions
- State of New York